New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European Psychiatric Association held April 6-9 in Budapest, Hungary. According to scientific posters of the event, cariprazine could be an appropriate treatment not only for early or late schizophrenia, but also for the difficult-to-treat dual diagnosis that combines schizophrenia and […]
Alkermes plc (Nasdaq: ALKS) today announced topline results from a phase 3, open-label extension study assessing the long-term safety, tolerability and durability of treatment effect of LYBALVI® (olanzapine and samidorphan) in patients with schizophrenia, schizophreniform disorder or bipolar I disorder for up to four years of treatment, following treatment received in prior LYBALVI studies. LYBALVI is approved in […]
The Foundation of Hope for Research and Treatment of Mental Illness will hold its 35th Annual Thad and Alice Eure Walk for Hope on Sunday, October 8, 2023, from 9:00 am-2:00 pm at the Angus Barn restaurant in Raleigh, N.C. The 5K annual walk, which raises money for mental illness research, also includes a festival […]
Ganesh Rajan, the author of “I, Me and Us” [Westland 2015] now follows up with a new fictional book, “God Flipped Me Off.” The author experienced the entire symptomatic spectrum of the imbalances caused by schizophrenia in his late teens, gaining insights in his later years until it culminated in its near-total remission. While various […]
